BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

385 related articles for article (PubMed ID: 9041834)

  • 1. Eosinophilic myositis with eosinophilic cellulitislike skin lesions. Association with increased serum levels of eosinophil cationic protein and interleukin-5.
    Trüeb RM; Lübbe J; Torricelli R; Panizzon RG; Wüthrich B; Burg G
    Arch Dermatol; 1997 Feb; 133(2):203-6. PubMed ID: 9041834
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rebound eosinophilia after treatment of hypereosinophilic syndrome and eosinophilic gastroenteritis with monoclonal anti-IL-5 antibody SCH55700.
    Kim YJ; Prussin C; Martin B; Law MA; Haverty TP; Nutman TB; Klion AD
    J Allergy Clin Immunol; 2004 Dec; 114(6):1449-55. PubMed ID: 15577851
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Wells' syndrome associated with idiopathic hypereosinophilic syndrome.
    Bogenrieder T; Griese DP; Schiffner R; Büttner R; Riegger GA; Hohenleutner U; Landthaler M
    Br J Dermatol; 1997 Dec; 137(6):978-82. PubMed ID: 9470919
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The role of eosinophilic granulocytes for the pathogenesis of atopic dermatitis /neurodermatitis. Eosinophilic products as markers of disease activity].
    Kapp A
    Hautarzt; 1993 Jul; 44(7):432-6. PubMed ID: 8365876
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Eosinophilic cationic protein (ECP) in skin disorders.
    Juhlin L; Venge P
    Acta Derm Venereol; 1991; 71(6):495-501. PubMed ID: 1685831
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interleukin-2 primes eosinophil degranulation in hypereosinophilia and Wells' syndrome.
    Simon HU; Plötz S; Simon D; Seitzer U; Braathen LR; Menz G; Straumann A; Dummer R; Levi-Schaffer F
    Eur J Immunol; 2003 Apr; 33(4):834-9. PubMed ID: 12672048
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Idiopathic eosinophilia].
    Trüeb RM
    Hautarzt; 1997 Mar; 48(3):153-6. PubMed ID: 9182084
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Eosinophilia-associated muscle disorders: an immunohistological study with tissue localisation of major basic protein in distinct clinicopathological forms.
    Cantarini L; Volpi N; Carbotti P; Greco G; Aglianò M; Bellisai F; Giannini F; Alessandrini C; Grasso G; Galeazzi M
    J Clin Pathol; 2009 May; 62(5):442-7. PubMed ID: 19139036
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Evaluation of tissue eosinophils in eosinophilic pneumonia].
    Hamada K; Nishikawa K; Ako H; Morii T; Kunimatsu M; Cho S; Tokuyama T; Narita N
    Nihon Kyobu Shikkan Gakkai Zasshi; 1992 Jun; 30(6):1072-6. PubMed ID: 1507682
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunnohistological assessment of intestinal eosinophil activation in patients with eosinophilic gastroenteritis and inflammatory bowel disease.
    Bischoff SC; Mayer J; Nguyen QT; Stolte M; Manns MP
    Am J Gastroenterol; 1999 Dec; 94(12):3521-9. PubMed ID: 10606314
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma eosinophil cationic protein, interleukin-5, and ECP/Eo count ratio in patients with various eosinophilic diseases.
    Park YJ; Oh EJ; Park JW; Kim M; Han K
    Ann Clin Lab Sci; 2006; 36(3):262-6. PubMed ID: 16951266
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A case of eosinophilic myositis proven by immunohistochemistry using antibodies against eosinophilic granule protein].
    Harada H; Mochizuki A; Ohkoshi N; Tamaoka A; Shoji S
    Rinsho Shinkeigaku; 2001 Jul; 41(7):387-9. PubMed ID: 11808347
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Eosinophilic gastroenteritis: ultrastructural evidence for a selective release of eosinophil major basic protein.
    Torpier G; Colombel JF; Mathieu-Chandelier C; Capron M; Dessaint JP; Cortot A; Paris JC; Capron A
    Clin Exp Immunol; 1988 Dec; 74(3):404-8. PubMed ID: 3233790
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of blood eosinophilia and the eosinophil cationic protein (ECP) in the serum of asthmatic children with varying degree of severity.
    Vilá-Indurain B; Muñoz-López F; Martín-Mateos M
    Allergol Immunopathol (Madr); 1999; 27(6):304-8. PubMed ID: 10611555
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of lacto-N-fucopentaose III (CD15)- and sialyl-Lewis X-bearing molecules and their functional properties in eosinophils from patients with the idiopathic hypereosinophilic syndrome.
    Satoh T; Knowles A; Li MS; Sun L; Tooze JA; Zabucchi G; Spry CJ
    Immunology; 1994 Oct; 83(2):313-8. PubMed ID: 7835953
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deposits of eosinophil granule proteins in eosinophilic cholecystitis and eosinophilic colitis associated with hypereosinophilic syndrome.
    Tajima K; Katagiri T
    Dig Dis Sci; 1996 Feb; 41(2):282-8. PubMed ID: 8601370
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis of interleukin-5 by activated eosinophils in patients with eosinophilic heart diseases.
    Desreumaux P; Janin A; Dubucquoi S; Copin MC; Torpier G; Capron A; Capron M; Prin L
    Blood; 1993 Sep; 82(5):1553-60. PubMed ID: 8364205
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Study of release of eosinophil cationic proteins (ECP and EPX) in the hypereosinophilic syndrome (HES) and other hypereosinophilic conditions.
    Bobbio-Pallavicini E; Confalonieri M; Tacconi F; Mainardi E; Della Porta R; Ceccato D; Maccario R; De Amici M
    Panminerva Med; 1998 Sep; 40(3):186-90. PubMed ID: 9785914
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recurrent cutaneous necrotizing eosinophilic vasculitis. A novel eosinophil-mediated syndrome.
    Chen KR; Pittelkow MR; Su D; Gleich J; Newman W; Leiferman KM
    Arch Dermatol; 1994 Sep; 130(9):1159-66. PubMed ID: 7522002
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Eosinophil-induced chronic active hepatitis in the idiopathic hypereosinophilic syndrome.
    Foong A; Scholes JV; Gleich GJ; Kephart GM; Holt PR
    Hepatology; 1991 Jun; 13(6):1090-4. PubMed ID: 2050327
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.